AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
GADODIAMIDE
10 registrations across 4 African markets— 10 active
Markets with GADODIAMIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| GADOSAM | 🇬🇭Ghana | — | active | Jul 2028 |
| GADOSAM | 🇬🇭Ghana | — | active | Jul 2028 |
| OMNISCAN TM SOLUTION FOR INJECTION (Each ml contains Gadodiamide 287mg) | 🇬🇭Ghana | — | active | Apr 2027 |
| OMNISCAN TM SOLUTION FOR INJECTION (Each ml contains Gadodiamide 287mg) | 🇬🇭Ghana | — | active | Apr 2027 |
| OMNISCAN 15 ml | 🇿🇦South Africa | GE Healthcare (Pty) Ltd | active | Jan 1900 |
| OMNISCAN 10 ml | 🇿🇦South Africa | GE Healthcare (Pty) Ltd | active | Jan 1900 |
| OMNISCAN 20 ml | 🇿🇦South Africa | GE Healthcare (Pty) Ltd | active | Jan 1900 |
| OMNISCAN solution injectable / 0,5 mmol / ml | 🇸🇳Senegal | GE HEALTH CARE | active | — |
| Omniscan 0.5 Injection Solution for injection | 🇳🇬Nigeria | — | active | — |
| OMNISCAN solution injectable / 0,5 mmol / ml | 🇸🇳Senegal | GE HEALTH CARE | active | — |
GADODIAMIDE in Africa — Regulatory Overview
GADODIAMIDE is registered across 4 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, South Africa, Senegal, Nigeria. AfricaRegulatory refreshes this data daily from official government sources.
Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.